发明名称 CAS9 EFFECTOR-MEDIATED REGULATION OF TRANSCRIPTION, DIFFERENTIATION AND GENE EDITING/LABELING
摘要 The present disclosure relates to methods of and systems for modifying the transcriptional regulation of stem or progenitor cells to promote their differentiation or reprogramming of somatic cells. Further, the labeling and editing of human genomic loci in live cells with three orthogonal CRISPR/Cas9 components allow multicolor detection of genomic loci with high spatial resolution, which provides an avenue for barcoding elements of the human genome in the living state.
申请公布号 US2015191744(A1) 申请公布日期 2015.07.09
申请号 US201414571818 申请日期 2014.12.16
申请人 University of Massachusetts 发明人 Wolfe Scot Andrew;Ma Hanhui;Pederson Thoru;Enuameh Metewo Selase Kosi;Kearns Nicola Anne;Genga Ryan Michael Jude;Maehr Rene;Zhang Shaojie;Naseri Ardalan;Garber Manuel
分类号 C12N15/86;C12Q1/68;C12N5/073;C12N5/074 主分类号 C12N15/86
代理机构 代理人
主权项 1. A method, comprising: a) providing; i) at least one stem cell comprising at least one specific genomic target; andii) a first and second lentiviral vectors, wherein said first lentiviral vector encodes a nuclease deficient Cas9-effector domain fusion protein and said second lentiviral vector comprises at least one sgRNA gene complementary with said specific genomic sequence; b) expressing said first and second lentiviral vectors in said at least one stem cell wherein a nuclease deficient Cas9-effector domain fusion protein/sgRNA complex is formed; and c) regulating transcription of said specific genomic target with said nuclease deficient Cas9-effector domain/sgRNA complex.
地址 Boston MA US